Log in
Enquire now
‌

US Patent 11406662 Microporous zirconium silicate for the treatment of hyperkalemia

Patent 11406662 was granted and assigned to zs pharma on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
zs pharma
zs pharma
Current Assignee
zs pharma
zs pharma
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11406662
Patent Inventor Names
Donald Jeffrey Keyser0
Alvaro F. Guillem0
Date of Patent
August 9, 2022
Patent Application Number
16850468
Date Filed
April 16, 2020
Patent Primary Examiner
‌
Tigabu Kassa
CPC Code
‌
C01B 39/00
‌
A61K 33/24
‌
A61K 33/244
‌
C01P 2002/72
‌
C01P 2004/52
‌
C01P 2004/61
‌
C01B 33/20
‌
C01B 39/02

The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11406662 Microporous zirconium silicate for the treatment of hyperkalemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.